MCID: INT046
MIFTS: 37

Intestinal Tuberculosis malady

Categories: Infectious diseases, Gastrointestinal diseases

Aliases & Classifications for Intestinal Tuberculosis

About this section

Aliases & Descriptions for Intestinal Tuberculosis:

Name: Intestinal Tuberculosis 11 13
Tuberculosis of Intestines 68
 
Tuberculosis of Intestine 11

Classifications:



External Ids:

Disease Ontology11 DOID:13282
ICD9CM32 014.8

Summaries for Intestinal Tuberculosis

About this section
Disease Ontology:11 A gastrointestinal tuberculosis that involves diffuse mucosal fold thickening, formation of ulcers and fistulae located in intestine. The infection has symptom abdominal pain, has symptom gastrointestinal bleeding, has symptom nausea and has symptom vomiting.

MalaCards based summary: Intestinal Tuberculosis, also known as tuberculosis of intestines, is related to gastrointestinal tuberculosis and tuberculosis, and has symptoms including abdominal pain, gastrointestinal bleeding and nausea. An important gene associated with Intestinal Tuberculosis is NT5E (5'-Nucleotidase Ecto). Affiliated tissues include intestine, liver and colon, and related mouse phenotypes are cardiovascular system and homeostasis/metabolism.

Related Diseases for Intestinal Tuberculosis

About this section

Graphical network of the top 20 diseases related to Intestinal Tuberculosis:



Diseases related to intestinal tuberculosis

Symptoms & Phenotypes for Intestinal Tuberculosis

About this section

Symptoms:

 11 (show all 4)
  • abdominal pain
  • gastrointestinal bleeding
  • nausea
  • vomiting

MGI Mouse Phenotypes related to Intestinal Tuberculosis according to GeneCards Suite gene sharing:

41
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053858.4ABCA3, ABCB8, CRP, LOXL2, NT5E
2MP:00053767.6ABCA3, ABCB8, CRP, LOXL2, NT5E

Drugs & Therapeutics for Intestinal Tuberculosis

About this section

Drugs for Intestinal Tuberculosis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 44)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1Liver ExtractsPhase 44067
2ColaNutraceuticalPhase 41946
3
Meloxicamapproved, vet_approvedPhase 38171125-38-75281106, 54677470
Synonyms:
(3E)-3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1
133687-22-6
2H-1,2-Benzothiazine-3-carboxamide, 4-hydroxy-2-methyl-N-(5-methylthiazolyl)-, 1,1-dioxide
4-Hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide
4-Hydroxy-2-methyl-N-(5-methyl-2-thiazoyl)-2H-1,2-benzothiazine-3-carboxamide-1,1-dioxide
4-hydroxy-2-mehtyl-N-(5-mehtyl-2-thiazolyl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide
4-hydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide
4-hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-2H-1,2-benzothiazine-3-carboxamide-1,1-dioxide
71125-38-7
AC-1325
AC1NQY12
AC1Q3XZW
AKOS000279442
Abbott brand of meloxicam
Almirall brand of meloxicam
Apo-meloxicam
Bio-0826
Boehringer Ingelheim brand of meloxicam
C065757
C08169
C14H13N3O4S2
CCRIS 9139
CHEMBL599
CID5281106
Co Meloxicam
D00969
DB00814
Dom-meloxicam
Europharma brand of meloxicam
FT-0082769
Gen-meloxicam
HMS1922D19
HMS2089B18
I06-0490
LS-40538
M1959
Masflex
 
Meloxicam
Meloxicam (JAN/USAN/INN)
Meloxicam [USAN:BAN:INN]
Meloxicamum
Meloxicamum [Latin]
Meloxicamum [latin]
Meloxivet
Metacam
Mobec
Mobic
Mobic (TN)
Mobic, Metacam, Parocin, Meloxicam
Mobicox
MolPort-002-885-839
Movalis
Movatec
Movicox
Méloxicam
Novo-meloxicam
PHL-meloxicam
PMS-meloxicam
Parocin
Promeco brand of meloxicam
Ratio-meloxicam
S1734_Selleck
SPECTRUM1504150
STK620505
Squibb brand of meloxicam
TL8005001
Tenaron
UH-AC 62XX
UHAC-62XX
UNII-VG2QF83CGL
UNII-vg2qf83cgl
Uticox
meloxicam
miloxicam
reumoxicam
4
AdalimumabapprovedPhase 3, Phase 1, Phase 2494331731-18-116219006
Synonyms:
331731-18-1
Adalimumab
Adalimumab (USAN/INN)
Adalimumab (genetical recombination)
 
Adalimumab (genetical recombination) (JAN)
D02597
Humira
Humira (TN)
Humira Pen
Ig gamma-1 chain C region
5Cyclooxygenase 2 InhibitorsPhase 3624
6Peripheral Nervous System AgentsPhase 3, Phase 223689
7Cyclooxygenase InhibitorsPhase 3, Phase 22870
8Antirheumatic AgentsPhase 3, Phase 2, Phase 110956
9Analgesics, Non-NarcoticPhase 3, Phase 26501
10AnalgesicsPhase 3, Phase 211733
11Anti-Inflammatory AgentsPhase 3, Phase 2, Phase 110729
12Anti-Inflammatory Agents, Non-SteroidalPhase 3, Phase 24443
13ImmunoglobulinsPhase 36394
14Antibodies, MonoclonalPhase 34039
15AntibodiesPhase 36394
16Antitubercular AgentsPhase 31343
17
Aspirinapproved, vet_approvedPhase 2115250-78-22244
Synonyms:
11126-35-5
11126-37-7
1oxr
2-(Acetyloxy)benzoate
2-(Acetyloxy)benzoic acid
2-Acetoxybenzenecarboxylic acid
2-Acetoxybenzoate
2-Acetoxybenzoic acid
2-Carboxyphenyl acetate
2349-94-2
26914-13-6
50-78-2
8-hour Bayer
98201-60-6
A 5376
A.S.A
A.S.A.
A.S.A. Empirin
A.S.A. empirin
A2093_SIGMA
A3160_SIGMA
A5376_SIGMA
A6810_SIGMA
AB1003266
AC 5230
AC1L1D8U
AC1Q1LA0
ACETYLSALICYLIC ACID
AI3-02956
AIN
AKOS000118884
ASA
Acenterine
Acesal
Acetal
Acetard
Aceticyl
Acetilsalicilico
Acetilum acidulatum
Acetisal
Acetol
Acetonyl
Acetophen
Acetosal
Acetosalic acid
Acetosalin
Acetoxybenzoic acid
Acetylin
Acetylsal
Acetylsalicylate
Acetylsalicylic acid
Acetylsalicylsaeure
Acetylsalicylsaure
Acetylsalicylsäure
Acetylsalycilic acid
Acetyonyl
Acetysal
Acetysalicylic acid
Acide acetylsalicylique
Acido O-acetil-benzoico
Acido acetilsalicilico
Acidum acetylsalicylicum
Acimetten
Acisal
Acylpyrin
Adiro
Aloxiprimum
Asacard
Asagran
Asatard
Ascoden-30
Aspalon
Aspec
Aspergum
Aspir-Mox
Aspirdrops
Aspirin
Aspirin (JP15/USP)
Aspirin [BAN:JAN]
Aspirina 03
Aspirine
Asprin
Aspro
Aspro Clear
Asteric
Azetylsalizylsaeure
Azetylsalizylsäure
BIDD:GT0118
BRN 0779271
Bay-e-4465
Bayer
Bayer Aspirin 8 Hour
Bayer Buffered
Bayer Extra Strength Aspirin For Migraine Pain
Bayer Plus
Benaspir
Bi-prin
Bialpirina
Bialpirinia
Bufferin
C01405
CCRIS 3243
CHEBI:15365
CHEMBL25
CID2244
Caprin
Cardioaspirin
Cardioaspirina
Cemirit
Claradin
Clariprin
Colfarit
Contrheuma retard
Coricidin
Crystar
D00109
D001241
DB00945
Decaten
Delgesic
Dispril
DivK1c_000555
Dolean pH 8
Duramax
ECM
EINECS 200-064-1
EU-0100038
Easprin
Easprin (TN)
Ecolen
Ecotrin
Empirin
Empirin with Codeine
Endosprin
Endydol
Entericin
Enterophen
 
Enterosarein
Enterosarine
Entrophen
Extren
Globentyl
Globoid
HMS1920E13
HMS2090G03
HMS2091K13
HMS501L17
HSDB 652
Helicon
I14-7505
IDI1_000555
Idragin
Istopirin
KBio1_000555
KBio2_001725
KBio2_002271
KBio2_004293
KBio2_004839
KBio2_006861
KBio2_007407
KBio3_002149
KBio3_002751
KBioGR_000398
KBioGR_002271
KBioSS_001725
KBioSS_002272
Kapsazal
Kyselina 2-acetoxybenzoova
Kyselina acetylsalicylova
LS-143
Levius
Lopac-A-5376
Lopac0_000038
MLS001055329
MLS001066332
MLS001336045
MLS001336046
Magnecyl
Measurin
Medisyl
Micristin
MolPort-000-871-622
NCGC00015067-01
NCGC00015067-04
NCGC00015067-09
NCGC00090977-01
NCGC00090977-02
NCGC00090977-03
NCGC00090977-04
NCGC00090977-05
NCGC00090977-06
NCGC00090977-07
NCI60_002222
NINDS_000555
NSC 27223
NSC27223
NSC406186
Neuronika
Novid
Nu-seals
Nu-seals aspirin
O-(Acetyloxy)benzoate
O-(Acetyloxy)benzoic acid
O-Acetoxybenzoate
O-Acetoxybenzoic acid
O-Acetylsalicylic acid
O-Carboxyphenyl acetate
O-accetylsalicylic acid
O-acetylsalicylic acid
PL-2200
Persistin
Pharmacin
Pirseal
Polopirin
Polopiryna
Premaspin
R16CO5Y76E [UNII]
Rheumin tabletten
Rheumintabletten
Rhodine
Rhonal
Ronal
S-211
SMR000059138
SP 189
SPBio_001838
SPECTRUM1500130
ST075414
Salacetin
Salcetogen
Saletin
Salicylic acid acetate
Salicylic acid, acetate
Salospir
Solfrin
Solprin
Solprin acid
Solpyron
Solupsan
Spectrum2_001899
Spectrum3_001295
Spectrum4_000099
Spectrum5_000740
Spectrum_001245
Spira-Dine
St. Joseph
St. Joseph Aspirin for Adults
Supac
Tasprin
Temperal
Toldex
Triaminicin
Triple-sal
UNII R16CO5Y76E
UNII-R16CO5Y76E
UNII=R16CO5Y76E
UNM-0000306102
Vanquish
WLN: QVR BOV1
XAXA
Xaxa
Yasta
ZORprin
acide 2-(acétyloxy)benzoïque
acide acétylsalicylique
aspirin
cMAP_000006
component of Midol
component of Synirin
nchem.859-comp6
o-Acetoxybenzoic acid
o-Carboxyphenyl acetate
o-acetoxybenzoic acid
o-carboxyphenyl acetate
salicylic acid acetate
ácido acetilsalicílico
18
InfliximabapprovedPhase 1, Phase 2392170277-31-3
Synonyms:
 
Ig gamma-1 chain C region
Remicade
19
Vorinostatapproved, investigationalPhase 1, Phase 2247149647-78-95311
Synonyms:
149647-78-9
1zz1
AC-1923
AC1L1K2K
BRD-K81418486-001-10-3
C111237
CCRIS 8456
CHEBI:45716
CHEMBL98
CID5311
D06320
DB02546
EC-000.2057
FT-0082592
LS-186548
LS-186997
LS-187780
MK-0683
MK0683
MLS001065855
Merck brand of Vorinostat
MolPort-003-850-293
N'-hydroxy-N-phenyloctanediamide
N-Hydroxy-N'-phenyl octanediamide
N-Hydroxy-N'-phenyloctanediamide
N-Hyrdroxy-N'-phenyloctanediamide
N-hydroxy-N'-phenyl-octane-1,8-diotic acid diamide
N-hydroxy-N'-phenyloctanediamide
N1-hydroxy-N8-phenyloctanediamide
NCGC00168085-02
 
NHNPODA
NSC-701852
NSC701852
OCTANEDIOIC ACID HYDROXYAMIDE PHENYLAMIDE
Octanedioic acid hydroxyamide phenylamide
S1047_Selleck
SAHA
SAHA cpd
SAHA, Suberoylanilide hydroxamic acid
SHH
SKI390
SMR000486344
SW-064652
Suberanilohydroxamic acid
SuberoylaN/Aide hydroxamic acid
Suberoylanilide hydroxamic acid
UNII-58IFB293JI
Vorinostat
Vorinostat (JAN/USAN)
Vorinostat MSD
Vorinostat [USAN]
Vorinostatum
WIN64652
ZINC01543873
Zolinza
Zolinza (TN)
Zolinza, MK-0683, SAHA
m344
nchembio.275-comp2
nchembio.313-comp1
nchembio815-comp18
suberoylanilide hydroxamic acid
20Gastrointestinal AgentsPhase 1, Phase 28402
21AntipyreticsPhase 21605
22Dermatologic AgentsPhase 1, Phase 25806
23Fibrinolytic AgentsPhase 22388
24Platelet Aggregation InhibitorsPhase 22516
25Histone Deacetylase InhibitorsPhase 1, Phase 2569
26
XylometazolineapprovedPhase 177526-36-35709
Synonyms:
 
Balminil
Xylomethazoline
27Interleukin-12Phase 1133
28
Albendazoleapproved, vet_approved8554965-21-82082
Synonyms:
((Propylthio)-5 1H-benzimidazolyl-2) carbamate de methyle
((Propylthio)-5 1H-benzimidazolyl-2) carbamate de methyle [French]
(5-(Propylthio)-1H-benzimidazol-2-yl)carbamic acid methyl ester
(5-Propylsulfanyl-1H-benzoimidazol-2-yl)-carbamic acid methyl ester
5-(Propylthio)-2-carbomethoxyaminobenzimidazole
54965-21-8
A4673_FLUKA
A4673_SIGMA
AB00052377
AC-015
AC1L1CVL
AC1Q2YKD
AKOS000540882
Albendazol
Albendazol [INN-Spanish]
Albendazole
Albendazole (JAN/USP/INN)
Albendazole Armstrong Brand
Albendazole Diba Brand
Albendazole Fustery Brand
Albendazole Hormona Brand
Albendazole Liferpal Brand
Albendazole Monohydrochloride
Albendazole Noe-Socopharm Brand
Albendazole Pfizer Brand
Albendazole Sanicoopa Brand
Albendazole Valdecasas Brand
Albendazole [USAN:INN:BAN:JAN]
Albendazolum
Albendazolum [INN-Latin]
Albendoral
Albenza
Albenza (TN)
Albenza, Eskazole, Zentel, Andazol, Albendazole
Armstrong Brand of Albendazole
BAS 00439961
BB_SC-1386
BIDD:GT0615
BIM-0051849.0001
BPBio1_000038
BRD-K79131256-001-04-7
BSPBio_000034
BSPBio_002548
Bendapar
Bilutac
C01779
CARBAMIC ACID, (5-(PROPYLTHIO)-1H-BENZIMIDAZOL-2-YL)-, METHYL ESTER
CAS-54965-21-8
CHEBI:16664
CHEBI:506787
CHEMBL1483
CID2082
CPD000036735
Carbamic acid, [5-(propylthio)-1H-benzimidazol-2-yl]-, methyl ester
ChemDiv1_000190
ChemDivAM_000003
D00134
D015766
DB00518
Diba Brand of Albendazole
Digezanol
Disthelm
Disthelm, Mediamix V
DivK1c_000704
EINECS 259-414-7
Endoplus
Eskazole
Fustery Brand of Albendazole
Gascop
HMS1568B16
HMS1922K04
HMS2090G19
HMS2093K13
HMS502D06
HMS587I14
HSDB 7444
Hormona Brand of Albendazole
I01-0380
IDI1_000704
InChI=1/C12H15N3O2S/c1-3-6-18-8-4-5-9-10(7-8)14-11(13-9)15-12(16)17-2/h4-5,7H,3,6H2,1-2H3,(H2,13,14,15,16)
KBio1_000704
 
KBio2_002012
KBio2_004580
KBio2_007148
KBioGR_000801
KBioSS_002012
LS-50618
Liferpal Brand of Albendazole
Lurdex
MLS000069722
Mediamix V Disthelm
Methyl 5-(propyl-thio)-2-benzimidazolecarbamate
Methyl 5-(propylthio)-2-benzimidazolecarbamate
Methyl [5-(Propylthio)benzimidazol-2-yl]carbamate
Methyl-5-[propylthio]-2-benzimidazole carbamate
Metiazol
MolPort-000-726-929
MolPort-000-760-571
MolPort-001-932-918
Monohydrochloride, Albendazole
NCGC00016876-01
NCGC00016876-02
NCGC00022896-03
NCGC00022896-04
NCGC00022896-05
NCGC00022896-06
NCGC00022896-07
NINDS_000704
NSC 220008
NSC220008
Noe Socopharm Brand of Albendazole
Noe-Socopharm Brand of Albendazole
O-Methyl N-(5-(propylthio)-2-benzimidazolyl)carbamate
Oprea1_429292
Oprea1_585016
Oprea1_640007
Pfizer Brand of Albendazole
Prestwick0_000247
Prestwick1_000247
Prestwick2_000247
Prestwick3_000247
Prestwick_675
Proftril
Ricobendazole
Rycobendazole
S1640_Selleck
SAM002589939
SK&F 62979
SK&F-62979
SK&F62979
SKF 62979
SKF-62979
SKF62979
SMR000036735
SPBio_002253
SPECTRUM1503903
STK387550
STL046130
STOCK2S-67946
Sanicoopa Brand of Albendazole
Smith Kline & French Brand of Albendazole
SmithKline Beecham Brand of Albendazole
Spectrum4_000201
Spectrum5_001567
Spectrum_001532
TL8003543
UNII-F4216019LN
V Disthelm, Mediamix
VU0239747-6
Valbazen
Valdecasas Brand of Albendazole
ZINC17146904
Zental
Zentel
[5-(Propylthio)benzimidazol-2-yl]carbamic Acid Methyl Ester
[5-(Propythio)-1H-benzimidazol-2-yl]carbamic acid methyl ester
albendazole
methyl N-(6-propylsulfanyl-1H-benzimidazol-2-yl)carbamate
methyl N-[6-(propylsulfanyl)-1H-1,3-benzodiazol-2-yl]carbamate
methyl [(2Z)-5-(propylsulfanyl)-1,3-dihydro-2H-benzimidazol-2-ylidene]carbamate
methyl [5-(propylsulfanyl)-1H-benzimidazol-2-yl]carbamate
methyl [5-(propylthio)-1H-benzimidazol-2-yl]carbamate
methyl [6-(propylsulfanyl)-1H-benzimidazol-2-yl]carbamate
29
Rifampinapproved34813292-46-15458213, 5381226
Synonyms:
1-b]furan-21-yl acetate
13292-46-1
3-(((4-Methyl-1-piperazinyl)imino)-methyl)rifamycin
3-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin SV
3-(4-Methylpiperazinyliminomethyl)-rifamycin SV
3-(4-Methylpiperazinyliminomethyl)rifamycin SV
3-([(4-Methyl-1-piperazinyl)imino]methyl)rifamycin SV
3-[(4-Methyl-1-piperazinyl)iminomethyl]rifamycin SV
3-[[(4-Methyl-1-piperazinyl)imino]-methyl]rifamycin
46713_FLUKA
46713_RIEDEL
62534-43-4
8-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin SV
8-(4-Methylpiperazinyliminomethyl) rifamycin SV
8-[[(4-Methyl-1-piperazinyl)imino[methyl]rifamycin
8-[[(4-Methyl-1-piperazinyl)imino]methyl]rifamycin sv
8-[[(4-Methylpiperazinyl)imino]methyl]rifamycin sv
83907_FLUKA
83907_SIGMA
8CI)
AZT + Rifampin
Abrifam
Archidyn
Arficin
Arzide
BA-41166E
BIDD:PXR0014
BPBio1_000561
BSPBio_000509
Ba 41166
Ba 41166/E
Benemicin
Benemycin
Bio-0621
C06688
C43H58N4O12
CAS-13292-46-1
CCRIS 551
CHEBI:28077
CHEBI:455936
CHEMBL180
CID5381226
CID5388984
CID5458213
CID5702112
CID6604339
CID6708473
CID6842115
CID6912767
CID6913622
CPD001906767
D00211
DB01045
DRG-0109
Dione 21-acetate
Dipicin
DivK1c_000550
Doloresum
EINECS 236-312-0
Eremfat
Famcin
Fenampicin
HMS1569J11
HMS1920P08
HMS2089F12
HMS2092G09
HMS501L12
HSDB 3181
KBio1_000550
KBio2_000919
KBio2_003487
KBio2_006055
KBio3_003018
KBioGR_001780
KBioSS_000919
L-5103
L-5103 Lepetit
LS-7689
MLS000028552
MLS001148237
MLS001333745
MolPort-000-767-051
MolPort-002-513-586
MolPort-003-666-281
MolPort-006-395-891
NCGC00016699-01
NCGC00017365-01
NCGC00018178-01
NCGC00022678-03
NCGC00022678-04
NCGC00022678-05
NCGC00160500-01
 
NCI60_000309
NINDS_000550
NSC 113926
NSC-113926
NSC113926
Piperine & Rifampicin
Prestwick0_000525
Prestwick1_000525
Prestwick2_000525
Prestwick3_000525
Prestwick_833
R-Cin
R/AMP
R0079
R3501_SIAL
R3501_SIGMA
R5777_SIGMA
R7382_SIGMA
RAMP
RFP
RMP
Ramp
Reserpine & Rifampicin
Rf
Rfamipicin
Rifa
Rifadin
Rifadin (TN)
Rifadin I.V
Rifadin I.V.
Rifadin IV
Rifadin Iv
Rifadin, Rimactane, Rifampicin, Rifampin
Rifadine
Rifagen
Rifaldazin
Rifaldazine
Rifaldin
Rifam
Rifamicin AMP
Rifamor
Rifampicin
Rifampicin & EEP
Rifampicin & Propolis
Rifampicin (JP15/INN)
Rifampicin SV
Rifampicin [INN:BAN:JAN]
Rifampicina
Rifampicina [INN-Spanish]
Rifampicine
Rifampicine [French]
Rifampicinum
Rifampicinum [INN-Latin]
Rifampin
Rifampin (USP)
Rifampin [USAN]
Rifamsolin
Rifamycin
Rifamycin AMP
Rifamycin Amp
Rifaprodin
Rifcin
Rifinah
Rifobac
Rifoldin
Rifoldine
Riforal
Rimactan
Rimactane
Rimactane (TN)
Rimactazid
Rimactin
Rimactizid
Rimazid
Rimycin
Rofact
S1764_Selleck
SAM002264646
SMR000058322
SMR000653525
SPBio_002430
SPECTRUM1500529
STK080143
Sinerdol
Spectrum3_001837
Spectrum4_001250
Spectrum5_002018
Spectrum_000439
TNP00313
Tubocin
UNII-VJT6J7R4TR
WLN: V1 WQ A&1 E&1 E1UN- AT6N DNTJ D1
nchembio884-comp4
rifampin
30
Certolizumab pegolapproved127428863-50-7
Synonyms:
428863-50-7
CDP870
Certolizumab pegol
 
Certolizumab pegol (USAN/INN)
Certolizumab pegol (genetical recombination)
Certolizumab pegol (genetical recombination) (JAN)
D03441
cimzia
31Nucleic Acid Synthesis Inhibitors4962
32Rifamycins103
33Cytochrome P-450 CYP3A Inducers1119
34rifamycin SV103
35Antiparasitic Agents2199
36Antibiotics, Antitubercular7180
37Anthelmintics446
38Antimitotic Agents5657
39Anti-Infective Agents22062
40Anti-Bacterial Agents11226
41Antiprotozoal Agents2051
42interferons2175
43Interferon-gamma152
44Immunosuppressive Agents13086

Interventional clinical trials:

(show all 25)
idNameStatusNCT IDPhase
1Prevalence of Colon Cancer in Pyogenic Liver AbscessCompletedNCT02032914Phase 4
2TB-IRIS NSAID Cox-2 Inhibitor Prevention TrialUnknown statusNCT02060006Phase 3
3Treatment Duration for Abdominal TuberculosisCompletedNCT01124929Phase 3
4Long-term Safety and Tolerability Study of Adalimumab in Subjects With Crohn's DiseaseCompletedNCT00195715Phase 3
5A Pilot Study of Adjunctive Aspirin for the Treatment of HIV Negative Adults With Tuberculous MeningitisCompletedNCT02237365Phase 2
6Safety and Tolerability of Vorinostat for the Treatment of Moderate-to-Severe Crohn s DiseaseRecruitingNCT03167437Phase 1, Phase 2
7Infliximab to Treat Crohn'S-like Inflammatory Bowel Disease in Chronic Granulomatous DiseaseTerminatedNCT00325078Phase 1, Phase 2
8STA-5326 Meslylate to Treat Gut Inflammation Associated With Common Variable ImmunodeficiencyCompletedNCT00263237Phase 1
9Intestinal Tuberculosis Diagnostics and the Differentiation From Crohn's DiseaseUnknown statusNCT01503099
10Development of a Prediction Model for Differential Diagnosis Between Intestinal Tuberculosis and Crohn's DiseaseCompletedNCT01392365
11The Effect of Parasitic Worm Infections on the Immune Response to Tuberculosis BacteriaCompletedNCT00342017
12Deworming Against TuberculosisCompletedNCT00857116
13Epidemiology of H. Pylori TransmissionCompletedNCT02740140
14Study of Patients With Strongyloides Stercoralis InfectionCompletedNCT00001245
15Immune Activation and Drug Absorption in HIV-Infected PatientsCompletedNCT01845298
16Pilot Survey of Dengue Fever in Solomon IslandsCompletedNCT01868399
17Treatment of Helminth co-Infection: Short-Term Effects on HIV-1 Progression Markers and Immune ActivationCompletedNCT00130910
18Remicade Safety Line (Crohn's Disease)(Study P03288)(COMPLETED)CompletedNCT00818272
19Surveillance of Humira Injection in Korean PatientsCompletedNCT01083121
20MRI Differentiating Gut TB and Crohn'sRecruitingNCT03096379
21Effect of Filarial Infection on Immune Responses in Latent TuberculosisRecruitingNCT01547884
22The Role of IGRA in Screening and Monitoring for TB During Anti TNF Therapy in Patients With IMIDActive, not recruitingNCT02135289
23Immune Reconstitution Syndrome in HIV-Infected Patients Taking Antiretroviral TherapyActive, not recruitingNCT00286767
24Parasitic Infections of the Gastrointestinal TractTerminatedNCT00001162
25Certolizumab Pegol for the Treatment of Patients With Active Rheumatoid Arthritis (RA) and Crohn's Disease (CD)TerminatedNCT01577264

Search NIH Clinical Center for Intestinal Tuberculosis

Genetic Tests for Intestinal Tuberculosis

About this section

Anatomical Context for Intestinal Tuberculosis

About this section

MalaCards organs/tissues related to Intestinal Tuberculosis:

36
Liver, Colon, Testes, Small intestine, Appendix, Kidney, Heart

FMA organs/tissues related to Intestinal Tuberculosis:

17
Intestine

Publications for Intestinal Tuberculosis

About this section

Articles related to Intestinal Tuberculosis:

(show top 50)    (show all 280)
idTitleAuthorsYear
1
Accuracy of computed tomographic features in differentiating intestinal tuberculosis from Crohn's disease: a systematic review with meta-analysis. (28522943)
2017
2
Predictive Model for Differentiating Crohn's Disease and Intestinal Tuberculosis: The Story Is Incomplete Without Imaging. (28050042)
2017
3
Meta-Analytic Bayesian Model For Differentiating Intestinal Tuberculosis from Crohn's Disease. (28045023)
2017
4
Endoscopic and clinical responses to anti-tubercular therapy can differentiate intestinal tuberculosis from Crohn's disease. (27813111)
2017
5
Primary Enterolith in a Patient with Intestinal Tuberculosis: A Case Report. (27853338)
2016
6
Predictive Factors for Differentiating Between Crohn's Disease and Intestinal Tuberculosis in Koreans. (27296940)
2016
7
Development and validation of visceral fat quantification as a surrogate marker for differentiation of Crohn's disease and Intestinal tuberculosis. (27532624)
2016
8
An Analysis of the Clinical, Endoscopic, and Pathologic Features of Intestinal Tuberculosis. (26974755)
2016
9
Misdiagnosis and Mistherapy of Crohn's Disease as Intestinal Tuberculosis: Case Report and Literature Review. (26735549)
2016
10
Proteome analysis of the macroscopically affected colonic mucosa of Crohn's disease and intestinal tuberculosis. (26988818)
2016
11
Intestinal tuberculosis masquerading as difficult to treat Crohn disease: a case report. (27557645)
2016
12
Differences in Clinical Manifestations according to the Positivity of Interferon-I^ Assay in Patients with Intestinal Tuberculosis. (27282272)
2016
13
Intestinal tuberculosis and Crohn's disease: challenging differential diagnosis. (26854750)
2016
14
Intestinal tuberculosis versus crohn's disease: Clinical and radiological recommendations. (27413261)
2016
15
Endoscopic Treatment of Intussusception due to Intestinal Tuberculosis. (28030916)
2016
16
Exploration of Serum Proteomic Profiling and Diagnostic Model That Differentiate Crohn's Disease and Intestinal Tuberculosis. (27997555)
2016
17
Clinical and Laboratory Diagnosis of Intestinal Tuberculosis. (27231171)
2016
18
The use of Masson's trichrome staining, second harmonic imaging and two-photon excited fluorescence of collagen in distinguishing intestinal tuberculosis from Crohn's disease. (27232282)
2016
19
Computerized tomography-based predictive model for differentiation of Crohn's disease from intestinal tuberculosis. (25966870)
2015
20
Computed tomographic enterography adds value to colonoscopy in differentiating Crohn's disease from intestinal tuberculosis: a potential diagnostic algorithm. (25675175)
2015
21
Genome-wide gene expression analysis for target genes to differentiate patients with intestinal tuberculosis and Crohn's disease and discriminative value of FOXP3 mRNA expression. (25969456)
2015
22
Multiple, Pan-Enteric Perforation Secondary to Intestinal Tuberculosis. (26798540)
2015
23
Extraintestinal manifestations of inflammatory bowel disease and intestinal tuberculosis: Frequency and relation with disease phenotype. (25663290)
2015
24
P285. A novel scoring system for differential diagnosis between Crohn's disease and intestinal tuberculosis: A prospective study. (25717761)
2015
25
High faecal calprotectin levels in intestinal tuberculosis are associated with granulomas in intestinal biopsies. (25522183)
2015
26
Differences in clinical features of Crohn's disease and intestinal tuberculosis. (25834333)
2015
27
Subcutaneous abscess at epidural catheter insertion site in a patient with intestinal tuberculosis. (26111664)
2015
28
The features of intestinal tuberculosis by contrast-enhanced ultrasound. (26173398)
2015
29
Differential diagnosis between Crohn's disease and intestinal tuberculosis using integrated parameters including clinical manifestations, T-SPOT, endoscopy and CT enterography. (26770348)
2015
30
Evaluation of intestinal tuberculosis by multi-slice computed tomography enterography. (26695641)
2015
31
Combined identifying granuloma and biopsy culture is useful for diagnosing intestinal tuberculosis. (25868516)
2015
32
P139. Predictive Factors for Differentiating between Crohn's disease and Intestinal tuberculosis in Korea. (25717600)
2015
33
Intestinal tuberculosis previously mistreated as Crohn's disease and complicated with perforation: a case report and literature review. (26180746)
2015
34
Critical complications of intestinal tuberculosis--a case report. (26305349)
2015
35
Perforated Intestinal Tuberculosis in a Non-AIDS Immunocompromised Patient. (26451879)
2015
36
Granulomas as the Most Useful Histopathological Feature in Distinguishing between Crohn's Disease and Intestinal Tuberculosis in Endoscopic Biopsy Specimens. (26656343)
2015
37
Seminar Report From the 2014 Taiwan Society of Inflammatory Bowel Disease (TSIBD) Spring Forum (May 24th, 2014): Crohn's Disease Versus Intestinal Tuberculosis Infection. (25691838)
2015
38
Mycobacterium avium Subsp. avium infection in four veal calves: differentiation from intestinal tuberculosis. (24689051)
2014
39
Differential diagnosis of intestinal tuberculosis from Crohn's disease and primary intestinal lymphoma in China. (25038210)
2014
40
Immune thrombocytopenic purpura induced by intestinal tuberculosis in a liver transplant recipient. (25009408)
2014
41
Fluorescent quantitative PCR of Mycobacterium tuberculosis for differentiating intestinal tuberculosis from Crohn's disease. (24519133)
2014
42
Intestinal tuberculosis in a child living in a country with a low incidence of tuberculosis: a case report. (25346193)
2014
43
Analysis of recent cases of intestinal tuberculosis in Japan. (24785886)
2014
44
Routine diagnosis of intestinal tuberculosis and Crohn's disease in Southern India. (24803814)
2014
45
Differential diagnosis of Crohn's disease and intestinal tuberculosis in patients with spontaneous small-bowel perforation. (24970687)
2014
46
Systematic review with meta-analysis: accuracy of interferon-gamma releasing assay and anti-Saccharomyces cerevisiae antibody in differentiating intestinal tuberculosis from Crohn's disease in Asians. (24910240)
2014
47
Visceral fat as a useful parameter in the differential diagnosis of Crohn's disease and intestinal tuberculosis. (25349562)
2014
48
Comparative study of intestinal tuberculosis and primary small intestinal lymphoma. (24764686)
2014
49
The diagnostic utility of mean platelet volume and red cell distribution width in active Crohn's disease and intestinal tuberculosis. (24749142)
2014
50
Intestinal tuberculosis: a diagnostically-challenging case misdiagnosed as Crohn's disease at colorectal biopsy. (24897777)
2014

Variations for Intestinal Tuberculosis

About this section

Expression for genes affiliated with Intestinal Tuberculosis

About this section
Search GEO for disease gene expression data for Intestinal Tuberculosis.

Pathways for genes affiliated with Intestinal Tuberculosis

About this section

GO Terms for genes affiliated with Intestinal Tuberculosis

About this section

Molecular functions related to Intestinal Tuberculosis according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1ATPase activityGO:00168879.8ABCA3, ABCB8
2ATPase activity, coupled to transmembrane movement of substancesGO:00426269.8ABCA3, ABCB8
3transporter activityGO:00052159.2ABCA3, ABCB8

Sources for Intestinal Tuberculosis

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet